abagovomab 45
abciximab 39
abituzumab 28
abrilumab 26
actoxumab 31
adalimumab 21
aducanumab 18
afasevikumab 20
alacizumab_pegol 15
alemtuzumab 36
alirocumab 25
amatuximab 56
andecaliximab 32
anifrolumab 28
anrukinzumab 21
aprutumab 19
aprutumab_ixadotin 19
arcitumomab 28
ascrinvacumab 15
atezolizumab 16
atinumab 20
avelumab 20
basiliximab 50
bavituximab 51
begelomab 38
benralizumab 36
bevacizumab_beta 25
bezlotoxumab 31
bimagrumab 29
bleselumab 28
blinatumomab 47
blosozumab 32
bococizumab 27
brazikumab 22
brentuximab_vedotin 44
briakinumab 21
brodalumab 27
brolucizumab 30
brontictuzumab 31
burosumab 28
cabiralizumab 34
camrelizumab 16
canakinumab 25
cantuzumab_ravtansin 56
carlumab 24
carotuximab 34
cergutuzumab_amunaleukin2 38
cergutuzumab_amunaleukin 38
certolizumab_pegol 28
cetiximab 53
citatuzumab_bogatox 31
cixutumumab 38
clivatuzumab_tetraxetan 30
codrituzumab 35
conatumumab 21
concizumab 33
crenezumab 23
crizanlizumab 31
crotedumab 25
dacetuzumab 26
daclizumab 23
dalotuzumab 37
dapirolizumab_pegol 29
daratumumab 18
dectrekumab 13
demcizumab 36
denosumab 11
depatuxizumab 32
depatuxizumab_mafodotin 32
dezamizumab 30
dinutuximab 47
diridavumab 32
domagrozumab 20
drozitumab 26
duligotuzumab 21
durvalumab 18
dusigitumab 31
efalizumab 38
efungumab 35
eldelumab 23
elezanumab 33
elgemtumab 15
elotuzumab 22
emactuzumab 29
emapalumab 32
emibetuzumab 26
enavatuzumab 28
enfortumab_vedotin 16
enoblituzumab 23
enokizumab 30
enoticumab 25
ensituximab 47
eptinezumab 21
erenumab 30
etaracizumab 18
etrolizumab 24
evinacumab 26
evolocumab 30
farletuzumab 9
fasinumab 31
fezakinumab 33
fibatuzumab 22
ficlatuzumab 32
firivumab 41
flanvotumab 31
fletikumab 37
foralumab 20
foravirumab 19
fremanezumab 35
fresolimumab 26
fulranumab 23
futuximab 39
galcanezumab 25
ganitumab 36
gantenerumab 18
gemetuzumab 39
gemtuzumab2 34
gemtuzumab 34
gevokizumab 31
girentuximab 32
glembatumumab 27
glembatumumab_vedotin 27
guselkumab 29
ibalizumab 35
ibritumomab 49
icrucumab 17
idarucizumab 42
ifabotuzumab 22
imalumab 19
imgatuzumab 27
inclacumab 26
indatuximab_ravtansin 42
indusatumab 24
inebilizumab 28
intetumumab 20
iodine_girentuximab 32
ipilimumab 12
iratumumab 21
isatuximab 43
itolizumab 30
ixekizumab 39
labetuzumab_govitecan 28
lambrolizumab 35
lampalizumab 31
lanadelumab 21
landogrozumab 21
laprituximab 37
lebrikizumab 43
lendalizumab 31
lenzilumab 27
lifastuzumab_vedotin 27
ligelizumab 32
lilotomab 47
lirilumab 33
lodelcizumab 26
lokivetmab 27
lorvotuzumab_mertansin 28
lucatumumab 33
lumretuzumab 29
lupartumab 20
lutikizumab 21
margetuximab 40
milatuzumab 48
mirvetuximab 45
mirvetuximab_soravtansin 45
modotuximab 51
mogamulizumab 32
monalizumab 33
motavizumab 41
moxetumomab_pasudotox 34
namilumab 32
naratuximab 38
naratuximab_emtansin 38
narnatumab 22
navicixizumab2 32
navicixizumab 37
navivumab 40
necitumumab 19
nemolizumab 34
nesvacumab 20
nivolumab 21
obiltoxaximab 29
obinutuzumab 39
ocaratuzumab 34
ofatumumab 24
olaratumab 29
olokizumab 26
omalizumab 23
onartuzumab 26
ontuxizumab 38
opicinumab 18
orticumab 17
otelixizumab 41
oxelumab 15
ozanezumab 40
pamrevlumab 15
panobacumab 32
parsatuzumab 32
pasotuxizumab 23
pateclizumab 23
patritumab 30
pembrolizumab 35
perakizumab 27
pidilizumab 28
pinatuzumab_vedotin 20
plozalizumab 34
pogalizumab 32
polatuzumab_vedotin 23
ponezumab 44
prezalumab 18
pritoxaximab 52
quilizumab 21
racotumomab 38
radretumab 20
ralpancizumab 29
ramucirumab 17
ranevetmab 35
ranibizumab 28
refanezumab 30
remtolumab 21
rilotumumab 25
rinucumab 26
risankizumab 38
rituximab 35
rivabazumab 26
robatumumab 22
roledumab 36
romosozumab 32
rontalizumab 27
rosmantuzumab 29
rozanolixizumab 27
sacituzumab 37
sacituzumab_govitecan 37
samalizumab 32
sapelizumab 25
sarilumab 20
secukinumab 21
seribantumab 20
setoxaximab 54
sifalimumab 24
siltuximab 34
simtuzumab 35
sirukumab 17
solanezumab 29
solitomab 38
stamulumab 31
suptavumab 31
suvizumab 22
tabalumab 27
tadocizumab 25
tamtuvetmab 38
tanezumab 27
tarextumab 15
tavolixizumab 26
telisotuzumab 38
teplizumab 26
tesidolumab 35
tezepelumab 34
tigatuzumab 20
tildrakizumab 29
timolumab 21
tisotumab 17
tosatoxumab 46
tositumomab 46
tralokinumab 43
trastuzumab 25
tregalizumab 25
trevogrumab 17
ublituximab 40
urelumab 30
ustekinumab 34
utomilumab 39
vadastuximab 37
vadastuximab_talirin 37
vandortuzumab_vedotin 25
vantictumab 29
vanucizumab2 25
vanucizumab 45
varlilumab 20
vatelizumab 29
vedolizumab 36
veltuzumab 26
vesencumab 14
vorsetuzumab 29
vorsetuzumab_mafodotin 29
vunakizumab 42
xentuzumab 23
zatuximab 51
